Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| epithelial cell | 5 studies | 20% ± 3% | |
| B cell | 3 studies | 19% ± 3% | |
| glutamatergic neuron | 3 studies | 29% ± 9% | |
| neuron | 3 studies | 22% ± 4% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 3 studies | 25% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| liver | 100% | 2242.64 | 226 / 226 | 100% | 17.41 | 405 / 406 |
| thymus | 100% | 4355.15 | 653 / 653 | 100% | 27.33 | 603 / 605 |
| prostate | 100% | 5873.80 | 245 / 245 | 100% | 32.30 | 500 / 502 |
| kidney | 100% | 3084.47 | 89 / 89 | 99% | 19.18 | 896 / 901 |
| pancreas | 100% | 3263.08 | 328 / 328 | 99% | 19.44 | 177 / 178 |
| uterus | 100% | 4628.69 | 170 / 170 | 99% | 21.30 | 456 / 459 |
| bladder | 100% | 2619.10 | 21 / 21 | 99% | 19.81 | 498 / 504 |
| intestine | 100% | 2661.40 | 966 / 966 | 98% | 14.59 | 518 / 527 |
| lung | 100% | 2423.17 | 577 / 578 | 98% | 16.91 | 1137 / 1155 |
| esophagus | 100% | 1896.88 | 1439 / 1445 | 98% | 12.30 | 180 / 183 |
| adrenal gland | 100% | 2910.90 | 258 / 258 | 98% | 18.91 | 225 / 230 |
| ovary | 100% | 4539.31 | 180 / 180 | 98% | 14.65 | 420 / 430 |
| breast | 100% | 3059.74 | 459 / 459 | 98% | 16.61 | 1091 / 1118 |
| stomach | 100% | 2473.66 | 358 / 359 | 97% | 12.33 | 276 / 286 |
| brain | 95% | 1558.81 | 2504 / 2642 | 100% | 23.35 | 705 / 705 |
| skin | 89% | 1418.18 | 1618 / 1809 | 97% | 13.83 | 457 / 472 |
| eye | 0% | 0 | 0 / 0 | 100% | 17.86 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 29.03 | 29 / 29 |
| spleen | 100% | 5966.12 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 8.08 | 1 / 1 |
| adipose | 100% | 3570.14 | 1201 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 99% | 2197.85 | 1319 / 1335 | 0% | 0 | 0 / 0 |
| muscle | 99% | 1662.94 | 793 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 18.05 | 44 / 45 |
| peripheral blood | 96% | 1837.22 | 896 / 929 | 0% | 0 | 0 / 0 |
| heart | 94% | 1036.63 | 806 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0005975 | Biological process | carbohydrate metabolic process |
| GO_1903561 | Cellular component | extracellular vesicle |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0015929 | Molecular function | hexosaminidase activity |
| GO_0102148 | Molecular function | N-acetyl-beta-D-galactosaminidase activity |
| GO_0004563 | Molecular function | beta-N-acetylhexosaminidase activity |
| Gene name | HEXD |
| Protein name | beta-N-acetylhexosaminidase (EC 3.2.1.52) Hexosaminidase D (EC 3.2.1.52) (Beta-N-acetylhexosaminidase) (Beta-hexosaminidase D) (Hexosaminidase domain-containing protein) (N-acetyl-beta-galactosaminidase) Hexosaminidase D |
| Synonyms | HEXDC |
| Description | FUNCTION: Has hexosaminidase activity. Responsible for the cleavage of the monosaccharides N-acetylglucosamine (GlcNAc) and N-acetylgalactosamine (GalNAc) from cellular substrates. Has a preference for galactosaminide over glucosaminide substrates . . |
| Accessions | K7EK54 ENST00000327949.15 [Q8WVB3-1] J3QKU6 ENST00000578130.5 J3KRH3 ENST00000578775.2 ENST00000337014.10 [Q8WVB3-2] Q8WVB3 ENST00000577944.5 ENST00000578632.1 ENST00000578616.5 J3KS46 ENST00000580235.5 K7EIV9 ENST00000583354.5 ENST00000581482.5 J3KT84 J3QLN1 J3KTD0 ENST00000582315.5 ENST00000644009.1 [Q8WVB3-1] ENST00000582429.5 J3QS29 J3QKL0 |